Press Releases May 19, 2026 04:00 AM

Futu to Report First Quarter 2026 Financial Results on May 28, 2026

Futu Holdings to Announce Q1 2026 Financial Results on May 28 with Conference Call

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
FUTU

Futu Holdings Limited, a technology-driven online brokerage and wealth management platform listed on Nasdaq, announced it will release its first quarter 2026 financial results on May 28, 2026, before U.S. market open. The company will host a conference call to discuss the results, requiring prior registration for participation.

Futu to Report First Quarter 2026 Financial Results on May 28, 2026
FUTU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Futu Holdings operates proprietary digital platforms Futubull and Moomoo offering comprehensive investment services, including trade execution, margin financing, securities lending, and wealth management.
  • The company integrates social media tools to create a user-centric network connecting investors, analysts, media, and key opinion leaders.
  • Futu also provides corporate services such as IPO distribution, investor relations, and ESOP solutions, expanding its financial ecosystem.

HONG KONG, May 19, 2026 (GLOBE NEWSWIRE) -- Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it will report its financial results for the first quarter ended March 31, 2026, before U.S. markets open on May 28, 2026.

Futu's management will hold an earnings conference call on Thursday, May 28, 2026, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time).

Please note that all participants will need to pre-register for the conference call, using the link

https://register-conf.media-server.com/register/BIec7483756a8d4ef789028b4abb4be479

It will automatically lead to the registration page of "Futu Holdings Ltd First Quarter 2026 Earnings Conference Call", where details for RSVP are needed.

Upon registering, all participants will be provided in confirmation emails with participant dial-in numbers and personal PINs to access the conference call. Please dial in 10 minutes prior to the call start time using the conference access information.

Additionally, a live and archived webcast of this conference call will be available at https://ir.futuholdings.com/.

About Futu Holdings Limited

Futu Holdings Limited (Nasdaq: FUTU) is an advanced technology company transforming the investing experience by offering fully digitalized financial services. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Company has embedded social media tools to create a network centered around its users and provide connectivity to users, investors, companies, analysts, media and key opinion leaders. The Company also provides corporate services, including IPO distribution, investor relations and ESOP solution services.

Investor Contact

Investor Relations
Futu Holdings Limited
ir@futuholdings.com


Risks

  • The announced earnings report may present results below market expectations, impacting investor sentiment in the technology and financial services sectors.
  • Regulatory changes or increased scrutiny in the online brokerage and wealth management industry could pose operational risks for Futu.
  • Market volatility or a downturn in investor trading activity may negatively affect Futu's revenue and growth prospects, impacting the wider fintech sector.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026